Meet the Team

Peptest has been developed by UK-based RD Biomed, a pharmaceutical development and diagnostic company based at Castle Hill Hospital in Hull, East Yorkshire.

Innovators in healthcare product development, RD Biomed focusses on gastroenterology and develops products that identify, prevent and treat various medical conditions, such as gastroesophageal reflux disease and laryngopharyngeal reflux.

In Peptest, RD Biomed has developed a novel diagnostic test which can rapidly detect the gastric enzyme pepsin in saliva/sputum and exhaled breath condensate samples.

Peptest team

Remembering Professor Peter Dettmar

Professor Peter Dettmar invented and developed Peptest and was the founder of RD Biomed.

He was also the former global Research and Development Director in Gastrointestinals for Reckitt Benckiser Healthcare (UK) Limited.

Peter had extensive experience in running product development programmes and clinical trials and more than 35 years’ experience of the pharmaceutical industry.

Get in touch…

Want to know more about Peptest? Or do you have a question for the team? Please use the contact form below.

Peptest Logo


Peptest™ is a single use in-vitro diagnostic device not for ingestion. It conforms to the European Directive 98/79/EC on in-vitro Diagnostic Medical Devices; this is shown by the CE mark of conformity.

Peptest™ kits are manufactured in the UK by RDBiomed Limited.

RDBiomed Limited
Castle Hill Hospital
Castle Road
HU16 5JQ, UK

VAT Number: GB 990 1918 96

Sign up

Subscribe To Our Email Newsletter

Be the first to know about EXCLUSIVE discount offers and the latest research into reflux.

You have Successfully Subscribed!